Blue Sky Biotech Enters Financing Deal
Worcester contract research firm Blue Sky Biotech Inc. has entered a partnership with Ampersand Ventures, a Boston-based private equity firm.
The companies did not disclose the terms of Ampersand's investment, but said the partnership would help Blue Sky expand and improve its services. As part of the deal, Ampersand General Partner Peter Glick will become chairman of Blue Sky's board of directors. The company also said three other new board members will be appointed this year.
Blue Sky, which is based at Gateway Park, offers research services and products to help speed up clients' projects. It says it serves the majority of the Fortune Top 10 pharmaceutical firms. Ampersand is a middle-market firm with a focus on later stage growth in the health care and industrial sectors.
WBJ Web Partners
Most Recent
0 Comments